Non-Immersive Virtual Reality for Gait and Balance Training in Children With Cerebral Palsy (NCT07612332) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Non-Immersive Virtual Reality for Gait and Balance Training in Children With Cerebral Palsy
Peru10 participantsStarted 2026-06-01
Plain-language summary
The goal of this clinical trial is to evaluate the feasibility and user satisfaction of a non-immersive VR rehabilitation system, i.e. Rehametrics, for gait and balance training in children with CP in children between 4 to 10 years old. Secondary objectives include assessing the system's impact on functional mobility, gross motor function, balance, active participation, and user experience.
Primary hypothesis: rehabilitation intervention with Rehametrics is feasible and well accepted in a clinical setting for children with CP aged 4 to 10 years.
Participants will train exercises related to balance and gait using Rehametrics platform
Who can participate
Age range
4 Years – 10 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age between 4 and 10 years (inclusive) at the time of enrollment.
* Confirmed clinical diagnosis of cerebral palsy documented in the medical record by a pediatric neurologist.
* Gross Motor Function Classification System (GMFCS) level I, II, or III
* Ability to stand independently or with minimal assistance for at least 30 seconds.
* Capacity to interact with a screen-based virtual environment (sufficient visual and cognitive ability to follow game instructions with therapist support).
* Written informed consent provided by parent or legal guardian.
* Availability to attend all scheduled sessions at the clinical site.
Exclusion Criteria:
* Severe or uncontrolled epilepsy that contraindicates interaction with visual stimuli (photosensitive epilepsy).
* Severe cognitive or behavioral impairment precluding participation in game-based VR interaction.
* Presence of acute musculoskeletal injuries or recent surgical interventions (within the preceding 3 months) affecting lower limb function.
* Participation in another rehabilitation research study during the study period.
* Visual impairment not correctable with glasses or lenses.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Proportion of eligible participants who complete all scheduled sessions
Timeframe: Immediately after the intervention.
2
User Satisfaction Evaluation Questionnaire (USEQ)
Timeframe: Immediately after the intervention
Trial details
NCT IDNCT07612332
SponsorUniversidad Nacional de San Agustin de Arequipa